Project Grant R03DK145781
- Federal Grant Award Summary Boston Medical Center Corporation received a $194,147 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 1, 2026, with completion targeted for November 30, 2030. The grant funds development and testing of a first-person storytelling (FPS) narrative video education intervention tailored specifically for...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Johns Hopkins University a $232,875 Project Grant (CFDA 93.847 – Diabetes, Digestive, and Kidney Diseases Extramural Research) beginning September 5, 2025, and concluding June 30, 2027. This award funds a mixed-methods study that characterizes clinician communication practices around glycemic management for people with diabetes and quantifies the most effective communication approaches....
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $199,130 to Massachusetts General Hospital (The General Hospital Corporation) on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This project grant funds research on Patient-Reported Outcome Measure (PROM) utilization to advance patient-centered chronic kidney disease (CKD) care through March 31, 2030. The research...
- Federal Project Grant Award Summary The University of California, San Francisco received a $192,215 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded July 15, 2025, with completion scheduled for March 31, 2030. This research initiative will develop and implement a risk communication tool designed to improve treatment persistence with sodium-glucose...
- Federal Project Grant Award Summary New York University School of Medicine received an $847,498 Project Grant awarded August 20, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds development and testing of AIMANAGE, an artificial intelligence-driven clinical decision support (CDS) system and chatbot designed to improve medication management for...
- Summary of Federal Project Grant Award See Yourself Health LLC, a woman-owned small business located in Beverly, Massachusetts, received a $771,632 Project Grant award from the National Institute on Minority Health and Health Disparities (NIMHD) under the Minority Health and Health Disparities Research program (CFDA 93.307) on April 29, 2025. The award funds the development and delivery of MIRAME SALUD, an innovative immersive diabetes self-management training platform specifically designed...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Harvard Pilgrim Health Care Inc. a $3.19 million Project Grant on March 13, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct the VALIDATE-DM study. This four-year research initiative, extending through February 28, 2029, focuses on improving the validity of linked real-world data (RWD) studies for diabetes mellitus research,...
- Federal Grant Award Summary Scripps Health received a $165,541 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with completion targeted for July 31, 2030. This K01 career development award supports Dr. San Diego's research to integrate continuous glucose monitoring (CGM) technology into diabetes self-management education...
- Federal Grant Award Summary Aurora Health Care, Inc. received a $762,556 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through June 30, 2030. The award supports development and testing of a novel, semi-automated self-monitoring feedback system designed to enhance weight management interventions in community settings....
- Federal Grant Award Summary The Jaeb Center for Health Research Foundation, Inc. received a $2.34M Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 3, 2025, to conduct research on implementing patch hybrid closed-loop (HCL) insulin delivery systems for cognitively impaired older adults with Type 1 Diabetes. The three-year research initiative,...
Massachusetts General Hospital, under a $123,750 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) on February 4, 2026, is developing AudibleDiabetesRx, an audio-based digital tool designed to address health literacy barriers to medication adherence in Type 2 Diabetes. The project, funded under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will extend the existing REACH-Español text message platform by incorporating on-demand audio content in Spanish. This intervention targets Latino adults with Type 2 Diabetes who experience disproportionately higher rates of suboptimal medication adherence, with particular focus on individuals struggling to read medication labels—a barrier identified by the majority of participants with elevated HbA1c levels (>9%) in preliminary pilot studies. The development and delivery of AudibleDiabetesRx addresses a critical gap in digital diabetes technology by providing scalable, audio-based medication information that overcomes written content limitations for individuals with low health literacy. Unlike earlier audio interventions requiring person-delivered education, this tool will deliver personalized, on-demand content addressing patient-reported adherence barriers through an automated digital platform. The project is expected to be completed by January 31, 2028, with the aim of improving glycemic control and medication adherence outcomes in this underserved population.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $123.8k | 2/4/26 |